Evolving Landscape on Sex Specific Status on Lung Cancer Management Moderating Effects, Risk Assessment

Fuente: Zenodo
Saved in:
Bibliographic Details
Main Authors: Sharma, Himanshu, Kaushik, Monika, Ashique, Sumel, Farid, Arshad, Taghizadeh-Hesary, Farzad
Format: Recurso digital
Language:English
Published: Zenodo 2024
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866902114036350976
author Sharma, Himanshu
Kaushik, Monika
Ashique, Sumel
Farid, Arshad
Taghizadeh-Hesary, Farzad
author_facet Sharma, Himanshu
Kaushik, Monika
Ashique, Sumel
Farid, Arshad
Taghizadeh-Hesary, Farzad
contents <p>The literature hasn’t given enough consideration to the connection between sex and the onset, prognosis, and course of treatment of lung cancer. Research on diseases associated with tobacco use has predominated, even though lung cancer that is not tied to smoking is on the rise and disproportionately affects women. However, depending on a patient’s sex, systemic therapy can have different effects and results, particularly when immunotherapy and chemotherapy are used. Further research is needed to fully comprehend these variances and address the rapidly changing lung cancer demographics worldwide. These results also highlight the growing awareness of the need for individualized therapies that account for variations in response and outcome related to sex.</p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_14621321
institution Zenodo
language eng
publishDate 2024
publisher Zenodo
record_format zenodo
spellingShingle Evolving Landscape on Sex Specific Status on Lung Cancer Management Moderating Effects, Risk Assessment
Sharma, Himanshu
Kaushik, Monika
Ashique, Sumel
Farid, Arshad
Taghizadeh-Hesary, Farzad
<p>The literature hasn’t given enough consideration to the connection between sex and the onset, prognosis, and course of treatment of lung cancer. Research on diseases associated with tobacco use has predominated, even though lung cancer that is not tied to smoking is on the rise and disproportionately affects women. However, depending on a patient’s sex, systemic therapy can have different effects and results, particularly when immunotherapy and chemotherapy are used. Further research is needed to fully comprehend these variances and address the rapidly changing lung cancer demographics worldwide. These results also highlight the growing awareness of the need for individualized therapies that account for variations in response and outcome related to sex.</p>
title Evolving Landscape on Sex Specific Status on Lung Cancer Management Moderating Effects, Risk Assessment
url https://doi.org/10.5281/zenodo.14621321